The global liposome drug delivery market is expected to reach US$ 6,992.95 million by 2027 from US$ 3,594.41 million in 2019. The market is estimated to grow at a CAGR of 8.8% from 2020 to 2027.
The growth of the market is attributed to a few key driving factors such as increasing prevalence of chronic diseases, growing demand for noninvasive drug delivery solutions, increasing R&D expenditures in pharmaceutical companies. However, high cost involved in the development of drug delivery systems is expected to obstruct the growth of the market to a certain extent during the forecast period.
With the improvements in medical science and certain oral drug delivery technologies, the noninvasive mode of drug delivery system is now ready to compete with traditional methods of injectable and painful routes of drug delivery. The non-invasive drug delivery systems include drug delivery via oral, topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and via alveolar membrane from inhaled medication. Patient compliance has been found to be much higher when administrated by noninvasive routes due to decreased pain involved in drug delivery. Therefore, these techniques are considered to be a preferred mode of drug delivery. The traditional drug delivery techniques, such as intramuscular, intravenous, and rectal drug administration are not preferred by certain patient populations owing to negative aspects associated with the traditional drug delivery techniques. The noninvasive method of drug delivery system has simplified dosing schedules and is accustomed to the patients. Moreover, noninvasive drug delivery system can significantly reduce the cost of clinical use because of self-administration of the drugs by the patients. The manufacturing costs are also comparatively less for noninvasive dosage forms than injections. Thus, due to advantages offered by noninvasive drug delivery devices, the liposome drug delivery market is expected to witness growth during the forecast period.
The global liposome drug delivery market is segmented into product, technology, application, and geography. The liposome drug delivery market, by product, is segmented into liposomal doxorubicin, liposomal paclitaxel, liposomal amphotericin B, and others. In 2019, the liposomal doxorubicin accounted for the largest share by product owing to the high efficacy of the drug exhibited in the treatment of cancer. Moreover, the liposomal doxorubicin is beneficial over its traditional counterparts in terms of toxicity and targeted drug delivery. The drug also exhibits significant recovery among patients suffering with HIV-related Kaposi's sarcoma and multiple myeloma. Based on technology, the liposome drug delivery market is segmented into stealth liposome technology, non-PEGylated liposome technology, depofoam liposome technology. Based on application, the liposome drug delivery market is segmented into fungal diseases, cancer therapy, pain management, viral vaccines, and photodynamic therapy.
Some of the crucial secondary sources included in the report are Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, National Institute of Cancer Prevention and Research (NICPR), Ministry of Food and Drug Safety (MFDS), International Diabetes Federation (IDF), and others.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
 1.3.1 Global Liposome Drug Delivery Market - By Product
 1.3.2 Global Liposome Drug Delivery Market - By Technology
 1.3.3 Global Liposome Drug Delivery Market - By Application
 1.3.4 Global Liposome Drug Delivery Market - By Geography
2. Liposome Drug Delivery Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Liposome Drug Delivery - Market Landscape
4.1 Overview
4.2 PEST Analysis
 4.2.1 Europe- PEST Analysis
 4.2.2 Asia Pacific- PEST Analysis
 4.2.3 Middle East & Africa
 4.2.4 South and Central America
4.3 Expert Opinion
5. Global Liposome Drug Delivery Market - Industry Dynamics
5.1 Market Drivers
 5.1.1 Rising prevalence of Chronic Diseases
 5.1.2 Growing Demand for Non-Invasive Drug Delivery Devices
 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
5.2 Market Restraints
 5.2.1 High Cost Involved in Development of Drug Delivery Systems
5.3 Market Opportunities
 5.3.1 Development of New Lipid Composition for Stability and Optimization of Drugs
5.4 Future Trends
 5.4.1 Increasing Popularity of Liposomes in Drug Delivery
5.5 Impact Analysis
6. Liposome Drug Delivery Market - Global Analysis
6.1 Global Liposome Drug Delivery Market Revenue Forecast And Analysis
6.2 Global Liposome Drug Delivery Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Liposome Drug Delivery Market Analysis - By Product
7.1 Overview
7.2 Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
7.3 Liposomal Doxorubicin
 7.3.1 Overview
 7.3.2 Liposomal Doxorubicin: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Liposomal Paclitaxel
 7.4.1 Overview
 7.4.2 Liposomal Paclitaxel: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
7.5 Liposomal Amphotericin B
 7.5.1 Overview
 7.5.2 Liposomal Amphotericin B: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
7.6 Others
 7.6.1 Overview
 7.6.2 Others: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
8. Liposome Drug Delivery Market - By Technology
8.1 Overview
8.2 Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
8.3 Stealth Liposome Technology
 8.3.1 Overview
 8.3.2 Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Non-PEGylated Liposome Technology
 8.4.1 Overview
 8.4.2 Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
8.5 DepoFoam Liposome Technology
 8.5.1 Overview
 8.5.2 DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Lysolipid Thermally Sensitive Liposome (LTSL) Technology
 8.6.1 Overview
 8.6.2 Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
9. Liposome Drug Delivery Market - By Application
9.1 Overview
9.2 Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
9.3 Fungal Diseases
 9.3.1 Overview
 9.3.2 Fungal Diseases: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Cancer Therapy
 9.4.1 Overview
 9.4.2 Cancer Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Pain Management
 9.5.1 Overview
 9.5.2 Pain Management: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Viral Vaccine
 9.6.1 Overview
 9.6.2 Viral Vaccine: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Photodynamic Therapy
 9.7.1 Overview
 9.7.2 Photodynamic Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
10. Liposome Drug Delivery Market - Geographic Analysis
10.1 North America: Liposome Drug Delivery Market
 10.1.1 Overview
 10.1.2 North America: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.1.3 North America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.1.4 North America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.1.5 North America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.1.6 North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
 10.1.7 US: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.1.7.1 US: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.1.7.2 US Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.1.7.3 US Skin aesthetic devices market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.1.7.4 US Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.1.8 Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.1.8.1 Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.1.8.2 Canada Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.1.8.3 Canada Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.1.8.4 Canada Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.1.9 Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.1.9.1 Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.1.9.2 Mexico Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.1.9.3 Mexico Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.1.9.4 Mexico Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.2 Europe: Liposome Drug Delivery Market
 10.2.1 Overview
 10.2.2 Europe: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.3 Europe Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.2.4 Europe Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.2.5 Europe Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.2.6 Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
 10.2.7 Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.7.1 Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.7.2 Germany Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.2.7.3 Germany Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.2.7.4 Germany Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.2.8 UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.8.1 UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.8.2 United Kingdom Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.2.8.3 United Kingdom Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.2.8.4 United Kingdom Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.2.9 France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.9.1 France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.9.2 France Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.2.9.3 France Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.2.9.4 France Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.2.10 Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.10.1 Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.10.2 Spain Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.2.10.3 Spain Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.2.10.4 Spain Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.2.11 Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.11.1 Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.2.11.2 Italy Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.2.11.3 Italy Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.2.11.4 Italy Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.3 Asia Pacific: Liposome Drug Delivery Market
 10.3.1 Overview
 10.3.2 Asia Pacific: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.3 Asia Pacific Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.3.4 Asia Pacific Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.3.5 Asia Pacific Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.3.6 Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
 10.3.7 China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.7.1 China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.7.2 China Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.3.7.3 China Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.3.7.4 China Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.3.8 Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.8.1 Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.8.2 Japan Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.3.8.3 Japan Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.3.8.4 Japan Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.3.9 India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.9.1 India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.9.2 India Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.3.9.3 India Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.3.9.4 India Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.3.10 South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.10.1 South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.10.2 South Korea Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.3.10.3 South Korea Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.3.10.4 South Korea Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.3.11 Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.11.1 Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.3.11.2 Australia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.3.11.3 Australia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.3.11.4 Australia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.4 Middle East & Africa: Liposome Drug Delivery Market
 10.4.1 Overview
 10.4.2 Middle East & Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
 10.4.3 Middle East & Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.4.4 Middle East & Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.4.5 Middle East & Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.4.6 Middle East & Africa: Liposome Drug Delivery Market, by Country, 2018 & 2027 (%)
 10.4.7 Saudi Arabia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.4.7.1 Saudi Arabia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.4.7.2 Saudi Arabia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.4.7.3 Saudi Arabia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.4.7.4 Saudi Arabia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.4.8 UAE: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.4.8.1 UAE: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.4.8.2 UAE Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.4.8.3 UAE Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.4.8.4 UAE Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.4.9 South Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.4.9.1 South Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.4.9.2 South Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.4.9.3 South Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.4.9.4 South Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
10.5 South and Central America: Liposome Drug Delivery Market
 10.5.1 Overview
 10.5.2 South and Central America: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.5.3 South and Central America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.5.4 South and Central America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.5.5 South and Central America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.5.6 South and Central America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
 10.5.7 Brazil: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.5.7.1 Brazil: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.5.7.2 Brazil Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.5.7.3 Brazil Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.5.7.4 Brazil Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
 10.5.8 Argentina: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.5.8.1 Argentina: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
 10.5.8.2 Argentina Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
 10.5.8.3 Argentina Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
 10.5.8.4 Argentina Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
11. Impact Of COVID-19 Pandemic On Global Liposome Drug Delivery Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Rest of the World: Impact Assessment of COVID-19 Pandemic
12. Liposome Drug Delivery Market -Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
 12.2.1 Overview
12.3 Inorganic Growth Strategies
 12.3.1 Overview
13. Liposome Drug Delivery Market -Company Profiles
13.1 Takeda Pharmaceutical Company Limited
 13.1.1 Key Facts
 13.1.2 Business Description
 13.1.3 Products and Services
 13.1.4 Financial Overview
 13.1.5 SWOT Analysis
 13.1.6 Key Developments
13.2 Novartis AG
 13.2.1 Key Facts
 13.2.2 Business Description
 13.2.3 Products and Services
 13.2.4 Financial Overview
 13.2.5 SWOT Analysis
 13.2.6 Key Developments
13.3 Luye Pharma Group
 13.3.1 Key Facts
 13.3.2 Business Description
 13.3.3 Products and Services
 13.3.4 Financial Overview
 13.3.5 SWOT Analysis
 13.3.6 Key Developments
13.4 Johnson & Johnson Services, Inc.
 13.4.1 Key Facts
 13.4.2 Business Description
 13.4.3 Products and Services
 13.4.4 Financial Overview
 13.4.5 SWOT Analysis
 13.4.6 Key Developments
13.5 Ipsen Pharma
 13.5.1 Key Facts
 13.5.2 Business Description
 13.5.3 Products and Services
 13.5.4 Financial Overview
 13.5.5 SWOT Analysis
 13.5.6 Key Developments
13.6 Gilead Sciences, Inc.
 13.6.1 Key Facts
 13.6.2 Business Description
 13.6.3 Products and Services
 13.6.4 Financial Overview
 13.6.5 SWOT Analysis
 13.6.6 Key Developments
13.7 Celsion, Inc.
 13.7.1 Key Facts
 13.7.2 Business Description
 13.7.3 Products and Services
 13.7.4 Financial Overview
 13.7.5 SWOT Analysis
 13.7.6 Key Developments
13.8 Astellas Pharma Inc.
 13.8.1 Key Facts
 13.8.2 Business Description
 13.8.3 Products and Services
 13.8.4 Financial Overview
 13.8.5 SWOT Analysis
 13.8.6 Key Developments
13.9 Acrotech Biopharma LLC
 13.9.1 Key Facts
 13.9.2 Business Description
 13.9.3 Products and Services
 13.9.4 Financial Overview
 13.9.5 SWOT Analysis
 13.9.6 Key Developments
13.10 Pacira BioSciences, Inc.
 13.10.1 Key Facts
 13.10.2 Business Description
 13.10.3 Products and Services
 13.10.4 Financial Overview
 13.10.5 SWOT Analysis
 13.10.6 Key Developments
14. Appendix
14.1 About
14.2 Glossary of Terms
LIST OF TABLES
Table 1. R&D Investments by major pharmaceutical companies
Table 2. North America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 3. North America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 4. North America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. US Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 6. US Skin aesthetic devices market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 7. US Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 8. Canada Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 11. Mexico Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 12. Mexico Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 14. Europe Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 15. Europe Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 16. Europe Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 17. Germany Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 18. Germany Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 19. Germany Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 20. United Kingdom Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 21. United Kingdom Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 22. United Kingdom Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 23. France Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 24. France Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 25. France Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 26. Spain Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 27. Spain Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 28. Spain Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 29. Italy Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 30. Italy Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 31. Italy Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 32. Asia Pacific Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 33. Asia Pacific Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 34. Asia Pacific Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 35. China Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 36. China Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 37. China Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 38. Japan Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 39. Japan Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 40. Japan Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 41. India Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 42. India Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 43. India Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 44. South Korea Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 45. South Korea Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 46. South Korea Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 47. Australia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 48. Australia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 49. Australia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 50. Middle East & Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 51. Middle East & Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 52. Middle East & Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 53. Saudi Arabia Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 54. Saudi Arabia Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 55. Saudi Arabia Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 56. UAE Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 57. UAE Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 58. UAE Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 59. South Africa Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 60. South Africa Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 61. South Africa Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 62. South and Central America Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 63. South and Central America Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 64. South and Central America Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 65. Brazil Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 66. Brazil Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 67. Brazil Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 68. Argentina Liposome Drug Delivery Market, by Product - Revenue and Forecast to 2027 (USD Million)
Table 69. Argentina Liposome Drug Delivery Market, by Technology - Revenue and Forecast to 2027 (USD Million)
Table 70. Argentina Liposome Drug Delivery Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 71. Recent Organic Growth Strategies in the Liposome Drug Delivery Market
Table 72. Recent Inorganic Growth Strategies In The Liposome Drug Delivery Market
Table 73. Glossary of Terms, Liposome Drug Delivery Market
LIST OF FIGURES
Figure 1. Liposome Drug Delivery Market Segmentation
Figure 2. Liposome Drug Delivery Segmentation, By Region
Figure 3. Global Liposome Drug Delivery Market Overview
Figure 4. The Liposomal Doxorubicin Segment Held Largest Share of Product Segment In Liposome Drug Delivery Market
Figure 5. Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Global Liposome Drug Delivery Market, By Geography (US$ Million)
Figure 7. Global Liposome Drug Delivery Market, Industry Landscape
Figure 8. Global Liposome Drug Delivery Market- Leading Country Markets (US$ Million)
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Global Liposome Drug Delivery Market - Revenue Forecast And Analysis - 2019- 2027
Figure 15. Global Liposome Drug Delivery Market - By Geography Forecast and Analysis - 2019- 2027
Figure 16. Market Positioning Of Key Players In Global Liposome Drug Delivery Market
Figure 17. Liposome Drug Delivery Market Revenue Share, by Product (2019 and 2027)
Figure 18. Liposomal Doxorubicin: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 19. Liposomal Paclitaxel: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Liposomal Amphotericin B: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Others: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 22. Liposome Drug Delivery Market, by Technology, 2019 and 2027 (%)
Figure 23. Stealth Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Non-PEGylated Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. DepoFoam Liposome Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Lysolipid Thermally Sensitive Liposome (LTSL) Technology: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Liposome Drug Delivery Market, by Application, 2019 and 2027 (%)
Figure 28. Fungal Diseases: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Cancer Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Pain Management: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Viral Vaccine: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 32. Photodynamic Therapy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (US$ Million)
Figure 33. North America: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
Figure 34. North America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 35. North America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 36. US: Liposome Drug Delivery market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Canada: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Mexico: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. Europe: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
Figure 40. Europe Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 41. Europe: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 42. Germany: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. UK: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. France: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 45. Spain: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 46. Italy: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 47. Asia Pacific: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
Figure 48. Asia Pacific Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 49. Asia Pacific: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 50. China: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. Japan: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. India: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. South Korea: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 54. Australia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 55. Middle East & Africa: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
Figure 56. Middle East & Africa Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 57. Middle East & Africa: Liposome Drug Delivery Market, by Country, 2018 & 2027 (%)
Figure 58. Saudi Arabia: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. UAE: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. South Africa: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 61. South and Central America: Liposome Drug Delivery Market, by Key Country - Revenue (2019) (USD Million)
Figure 62. South and Central America Liposome Drug Delivery Market Revenue and Forecast to 2027 (USD Million)
Figure 63. South and Central America: Liposome Drug Delivery Market, by Country, 2019 & 2027 (%)
Figure 64. Brazil: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 65. Argentina: Liposome Drug Delivery Market - Revenue and Forecast to 2027 (USD Million)
Figure 66. Impact of COVID-19 Pandemic In North American Country Markets
Figure 67. Impact of COVID-19 Pandemic In European Country Markets
Figure 68. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
Figure 69. Impact Of COVID-19 Pandemic In Rest of the World Market
Takeda Pharmaceutical Company Limited
Novartis AG
Luye Pharma Group
Ipsen Pharma
CELSION, Inc.
Gilead Sciences, Inc.
Astellas Pharma, Inc.
Johnson & Johnson Services, Inc.
Acrotech Biopharma, Inc.
Pacira Biosciences, Inc.